Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Sofosbuvir and Velpatasvir
DRUG
2 trials
Sponsors
National Taiwan University Hospital
, Hannover Medical School
Conditions
Acute Hepatitis C
Hepatitis C
Hepatitis C Virus Infection, Response to Therapy of
Human Immunodeficiency Virus
Phase 2
Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/Velpatasvir
Completed
NCT03818308
Hannover Medical School
Acute Hepatitis C, Hepatitis C
Start: 2019-05-28
End: 2021-06-08
Updated: 2021-07-06
Phase 4
Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients
Completed
NCT03250910
National Taiwan University Hospital
Hepatitis C Virus Infection, Response to Therapy of, Human Immunodeficiency Virus
Start: 2016-08-01
End: 2017-10-31
Updated: 2017-12-08
Related Papers
Sofosbuvir plus velpatasvir for 8 weeks in patients with acute hepatitis C: The HepNet acute HCV-V study
JHEP Reports
2022-12-16
19 citations